Intensified conditioning regimens improved disease‐free survival and engraftment after unrelated single‐unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation-Reference-Cited by-同舟云学术

Intensified conditioning regimens improved disease‐free survival and engraftment after unrelated single‐unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation

Published:2022-10-31 Issue:1 Volume:41 Page:147-158
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Konuma Takaaki¹^ORCID,Kanda Junya²,Uchida Naoyuki³,Nishijima Akihiko⁴,Tanaka Masatsugu⁵,Ozawa Yukiyasu⁶,Sawa Masashi⁷,Onizuka Makoto⁸,Ota Shuichi⁹,Maruyama Yumiko¹⁰,Kanda Yoshinobu¹¹^ORCID,Kawakita Toshiro¹²,Ara Takahide¹³,Eto Tetsuya¹⁴,Nakamae Hirohisa¹⁵,Kimura Takafumi¹⁶,Fukuda Takahiro¹⁷,Atsuta Yoshiko¹⁸¹⁹,

Affiliation:

1. Department of Hematology/Oncology The Institute of Medical Science The University of Tokyo Tokyo Japan

2. Department of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan

3. Department of Hematology Toranomon Hospital Tokyo Japan

4. Hematology Division Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

5. Department of Hematology Kanagawa Cancer Center Yokohama Japan

6. Department of Hematology Japanese Red Cross Nagoya First Hospital Nagoya Japan

7. Department of Hematology and Oncology Anjo Kosei Hospital Anjo Japan

8. Department of Hematology and Oncology Tokai University School of Medicine Isehara Japan

9. Department of Hematology Sapporo Hokuyu Hospital Sapporo Japan

10. Department of Hematology University of Tsukuba Hospital Tsukuba Japan

11. Division of Hematology Jichi Medical University Saitama Medical Center Saitama Japan

12. Department of Hematology National Hospital Organisation Kumamoto Medical Center Kumamoto Japan

13. Department of Hematology Hokkaido University Hospital Sapporo Japan

14. Department of Hematology Hamanomachi Hospital Fukuoka Japan

15. Hematology Graduate School of Medicine Osaka City University Osaka Japan

16. Preparation Department Japanese Red Cross Kinki Block Blood Center Osaka Japan

17. Department of Hematopoietic Stem Cell Transplantation National Cancer Center Hospital Tokyo Japan

18. Japanese Data Center for Hematopoietic Cell Transplantation Nagoya Japan

19. Department of Registry Science for Transplant and Cellular Therapy Aichi Medical University School of Medicine Nagakute Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3094

Reference51 articles.

1. Dose intensity for conditioning in allogeneic hematopoietic cell transplantation: can we recommend “when and for whom” in 2021?

2. Nonmyeloablative allogeneic hematopoietic cell transplantation

3. Granulocyte colony-stimulating factor combined regimen in cord blood transplantation for acute myeloid leukemia: a nationwide retrospective analysis in Japan

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine Learning Prediction Model for Neutrophil Recovery after Unrelated Cord Blood Transplantation;Transplantation and Cellular Therapy;2024-04

2. Association of individual comorbidities with outcomes in allogeneic hematopoietic cell transplantation from unrelated adult donors versus unrelated cord blood: A study on behalf of the Donor/Source and Transplant Complications Working Groups of the Japanese Society for Transplantation and Cellular Therapy;American Journal of Hematology;2024-01-02

3. Pretransplantation EASIX Score Predicts Nonrelapse and Overall Mortality of Adult Patients Undergoing Single-Unit Unrelated Cord Blood Transplantation;Transplantation and Cellular Therapy;2023-09

4. 本邦における成人に対する単一ユニットを用いた臍帯血移植;Japanese Journal of Transplantation and Cellular Therapy;2023

5. Lower probability of relapse after myeloablative cord blood transplantation for patients with refractory AML;British Journal of Haematology;2022-12-21